Vimarsana
Biggest News Aggregation in the World

Page 39 - Development Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development Platform Today - Breaking & Trending Today

Marvell Announces Innovative CXL Development Platform for Multi-Host Memory Pooling - Vimarsana News

Marvell Announces Innovative CXL Development Platform for Multi-Host Memory Pooling

/PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced a Compute Express Link™...

More strength for ASEAN's cultural and creative community - Vimarsana News

More strength for ASEAN's cultural and creative community

James Kon The Sultanate reaffirms the role of cultural and creative industries as an enabler and driver for ASEAN socio-economic growth and welcomes the Siem Reap Declaration on Promoting a Creative and Adaptive ASEAN Community to support the cultural and creative economy. This was underscored by Minister of Culture, Youth and Sports Dato Seri Setia […]

Neptune Software named a Leader in G2's Inc.'s Fall 2022 Grid® Report - Vimarsana News

Neptune Software named a Leader in G2's Inc.'s Fall 2022 Grid® Report

/PRNewswire/ -- Neptune Software, the leading low-code development platform for SAP processes, today announced that it has been named a leader within G2's Low...

Cloud Excellence Awards 2022 - Winners announced - Vimarsana News

Cloud Excellence Awards 2022 - Winners announced

Congratulations to all of our 2022 winners

EQS-News: Advanced AI Drug Development Platform 'DeepMatcher®' 2.0 Launches Worldwide (226330.KQ) - Vimarsana News

EQS-News: Advanced AI Drug Development Platform 'DeepMatcher®' 2.0 Launches Worldwide (226330.KQ)

EQS-News: Syntekabio, Inc. Advanced AI Drug Development Platform 'DeepMatcher®' 2.0 Launches Worldwide (226330.KQ) 21.09.2022 / 16:08 CET/CEST The issuer is solely responsible for the content of this announcement. SyntekaBio (226330.KQ)(226330:KS), an AI drug discovery and development company, a...